Hobart W. Harris, M.D., M.P.H.

              Curriculum Vitae

CURRICULUM VITAE

HOBART W. HARRIS, MD, MPH, FACS

513 Parnassus Avenue, Room S-301

San Francisco, CA 94143-0104

Office: (415) 514-3891

Fax: (415) 476-0164

e-mail: hobart.harris@ucsf.edu

EDUCATION:

1975-1979              Harvard College, Cambridge, MA              A.B.              Biology, magna cum laude

1979-1983              Harvard Medical School, Boston, MA              M.D.              Medicine, cum laude

1983-1984              Harvard School of Public Health, Boston, MA              M.P.H.              General Studies

1984-1985              University of California, San Francisco              Intern              Surgery

1985-1993              University of California, San Francisco              Resident              Surgery

7/93-12/93              University of Hong Kong,              Fellowship              Hepatobiliary Surgery
Queen Mary Hospital, Hong Kong, P.R.C.             

2/05-7/05              University of Louisville, Louisville, KY              Fellowship              ERCP

EMPLOYMENT HISTORY:

2002-present              University of California, San Francisco                            Professor of Surgery

2002-2020              University of California, San Francisco                            Chief, Division of General Surgery

2002-2008;               University of California, San Francisco                            Vice Chair, Department of Surgery

2013-2018              University of California, San Francisco                             Vice Chair, Department of Surgery

2000-2002              University of California, San Francisco                            Associate Professor of Surgery

1994-2000              University of California, San Francisco                            Assistant Professor of Surgery

7/93-12/93              University of Hong Kong,                                                        Honorary Clinical Associate

                            Queen Mary Hospital

2016-2017              Zuckerberg San Francisco General Hospital &
                            Trauma Center                                                                      Acting Chief of Surgery

LICENSES AND CERTIFICATIONS:

1986                            Medical license, California              (No. G57599)

1994                            Certified, American Board of Surgery                            (No. 38995)

2003                            Re-Certified, American Board of Surgery

2014                            Re-Certified, American Board of Surgery

2024                            Re-Certified, American Board of Surgery

HONORS AND AWARDS:

1976              John Harvard Scholarship (academic scholarship)

1984                            National Medical Foundation Fellowship (academic scholarship)

1988                            UCSF Black Heritage Month Steering Committee Biomedical Sciences Training Award

1988 - 1991              National Research Service Fellowship Award (F32, Department of Health

                            and Human Services Research Grant)

1989 - 1992              Achievement Reward for College Scientists (ARCS, private research grant)

1990                            Alpha Omega Alpha (Medical Honors Society), elected to San Francisco Chapter in 1990

1991                            Resident Research Award, Department of Surgery, University of California, San Francisco
 

HONORS AND AWARDS (Continued):

1993                            House Staff Teaching Award, University of California, San Francisco Medical School

              Class of 1993

1994 - 1998              Robert Wood Johnson Minority Medical Faculty Development Program Fellowship

1994 - 1999              TOP Award, University of California, San Francisco

1995 - 1997              American College of Surgeons Faculty Fellowship

1998                            Clinical Faculty Teaching Award, IUCSF Medical School, Class of 1998

1999              Teaching Award, University of California, San Francisco Medical School, Black Health Alliance

2000                                 Royal College of Surgeons Traveling Fellowship

2003                            James IV Traveling Fellowship

2004                            Kaiser Teaching Award, Clinical Faculty, UCSF School of Medicine Class of 2004

2006              Nominated, Kaiser Teaching Award, Clinical Faculty, UCSF School of Medicine Class of 2006

2008                            J. Englebert Dunphy Chair in Surgery (endowed chair)

2011                            Mentorship Award, UCSF Department of Surgery Chief Resident Class of 2011

2011                            Catalyst Award, UCSF Clinical & Translational Science Institute & Catalyst Program of                                           Innovation Ventures

2013                            Bridging the Gap Award, QB3 & Rogers Family Foundation

2013              Lim/Thomas Faculty Teaching Award, UCSF Department of Surgery, Chief Resident Class of 2013

2014                            Teaching Award, UCSF Department of Surgery Chief Resident Class of 2014

2014                            Rosenman Institute Innovation Award, QB3 & UCSF Department of Surgery

2015              Lim/Thomas Faculty Teaching Award, UCSF Department of Surgery, Chief Resident Class of 2015

2015                            Excellence in Teaching Award, Haile T. Debas Academy of Medical Educators

2017                            Catalyst Award, UCSF Clinical & Translational Science Institute & Catalyst Program of                                           Innovation Ventures

2019                            Nominated for the Academic Senate Distinction in Mentoring Award

2019                            Gold-Headed Cane Faculty Award

2020                            Medical Student Teaching Award, UCSF Department of Surgery

2021                            Cracchiolo Visiting Professor, University of Florida, Department of Surgery

2021              Roland S. Philip Surgical Innovations Visiting Professor, Cleveland Clinic, Department of                             General Surgery

2022                            Daniel M. Caruso Visiting Professor, Creighton Phoenix Department of Surgery

2022                            Winfield L. Butsch Memorial Lecturer, University at Buffalo Department of Surgery

2023              George Washington Carver Innovation Award, t.Lab 10th Annual Black Tie Ball, Kettering               Institute, Flint, MI

2023              Excellence in Mentoring Award for 2023 from the Haile T. Debas Academy of Medical Educators

MEMBERSHIPS:

1994                            Naffziger Society

1994 – 2009              Association for Academic Surgery

1995                            Society for Surgery of the Alimentary Tract

1996                            Society of Black Academic Surgeons

1996 – 2015              International Endotoxin Society

1997                            American College of Surgeons, Fellow

1997                            San Francisco Surgical Society

1997                            Surgical Infection Society

1997                            Shock Society

2000 – 2020              Society of University Surgeons

MEMBERSHIPS (Continued):

2000 – 2022              American Hepato-Pancreato-Biliary Association

2000                                 Pacific Coast Surgical Association

2002              International Hepato-Pancreato-Biliary Association

2005              American Surgical Association

2006              Surgical Biology Club I

2007              James IV Association of Surgeons, Inc.

2011                            American Hernia Society

PROFESSIONAL COMPETENCE:

National/International (selected presentations)

Forum on Fundamental Surgical Problems, American College of Surgeons, October 23-28, 1988 (oral presentation), Chicago, IL.

Sixtieth Annual Meeting of the Pacific Coast Surgical Association, February 22, 1989 (oral presentation), Vancouver, Canada.

Thirty-Second Annual University Surgical Resident’s Conference, Society of University Surgeons, February 10, 1990 (oral presentation), Los Angeles, CA.

1990 AAP/ASCI/AFCR National Meeting, Washington, D.C., May 4-7, 1990 (poster)

St. Joseph’s Hospital, “Hepatic Resections:  Total Vascular Exclusion”, Department of Surgery, April 2, 1995, Houston, TX.

University of California, San Francisco, Grand Rounds “Surgical Management of Benign Liver Tumors”, Department of Medicine, Division of Gastroenterology, October 18, 1995, San Francisco, CA.

University of California, San Francisco, General Surgery Postgraduate Course, “Recurrent Pyogenic Cholangitis”, April 25, 1996, San Francisco, CA.

Forum on Fundamental Surgical Problems, American College of Surgeons, October 6-11, 1996 (oral presentation), San Francisco, CA.

Fourth Conference of the International Endotoxin Society, Nagoya, Japan, October 22-25, 1996 (poster)

Fourth International Congress on The Immune Consequences of Trauma, Shock and Sepsis, Munich, Germany, March 4-8, 1997 (oral presentation)

Fifty-Seventh Annual Meeting of the American Association for the Surgery of Trauma, Waikoloa, HI, September 24-27, 1997 (poster)

Forum on Fundamental Surgical Problems, American College of Surgeons, Chicago, IL, October 12-17, 1997 (oral presentation)

Black Lion Hospital, Medical Director’s Office, “Introduction to Laparoscopic Surgery”, May 7, 1996, Addis Ababa, Ethiopia.

St. Joseph’s Hospital, Department of Surgery, “Necrotizing pancreatitis,” April 8, 1999, Houston, TX.

University of California, San Francisco, General Surgery Postgraduate Course, “Surgical Management of Necrotizing Pancreatitis”, April 22, 1999, San Francisco, CA.

University of California, Fresno, Department of Surgery, "Acute Pancreatitis," October 11, 1999, Fresno, CA.

International Gastro-Surgical Club, 9th World Congress, "Necrotizing Pancreatitis: Surgical Approaches," October 19-23, 1999, Nagasaki, Japan.

East Bay Surgical Society, "Acute pancreatitis, medical and surgical management," November 30, 1999, Oakland, CA.

Glasgow Royal Infirmary, Department of Surgery, "Hepatic Lipoproteins and Sepsis," October 19, 2000, Glasgow, Scotland.

Glasgow Royal Infirmary, Department of Surgery, "Necrotizing Pancreatitis," October 20, 2000, Glasgow, Scotland.

General Infirmary at Leeds, Department of Surgery, "Surgical Management of Necrotizing Pancreatitis," October 24, 2000, Leeds, England.

University of Liverpool, "Necrotizing Pancreatitis: Controversies in Management," October 25, 2000, Liverpool, England.

Imperial College School of Medicine, The Hammersmith Hospital, "Molecular Pathogenesis of Acute Pancreatitis," October 27, 2000, London, England.

University of California, San Francisco, Department of Surgery, “Integrated Soft Tissue Infection Services," May 9, 2001, San Francisco, CA.

University of California, Davis-East Bay, Department of Surgery, “Integrated Soft Tissue Infections Services," August 23, 2001, Oakland, CA.

Edinburgh Royal Infirmary, Department of Surgery, "Endogenous lipoproteins attenuate the response to endotoxin in humans," September 18, 2001, Glasgow, Scotland.

Marin General Hospital, Committee on Continuing Medical Education, “Abdominal Sepsis,” December 18, 2001, Marin, CA.

O’Connor Hospital, Committee on Continuing Medical Education, “Necrotizing Pancreatitis,” January 29, 2002, San Jose, CA.

University of Texas-Southwestern, Department of Surgery, “Lipoproteins as Agents of Innate Immunity,” March 20, 2002, Dallas, TX.

University of Arizona, Department of Surgery, “Surgical Management of Necrotizing Pancreatitis,” April 3, 2002, Tucson, AZ.

University of California, San Francisco, General Surgery Postgraduate Course, “Abdominal Sepsis”, April 13, 2002.

O’Connor Hospital, Committee on Continuing Medical Education, “Soft Tissue Infections,” June 11, 2002, San Jose, CA.

Twenty-fifth Annual Meeting of the Shock Society, “Lipopolysaccharide and Toll-like Receptors,” Big Sky, MT, June 8-11, 2002.

Seventh Biennial Conference of the International Endotoxin Society, “Lipemia of Sepsis: triglyceride-rich lipoproteins as agents of innate immunity,” Arlington, VA, July 17-21, 2002.

University of California, San Francisco, Department of Surgery, “The Three Princes of Serendip and the Pancreas," January 22, 2003, San Francisco, CA.

Thirty-second Critical Care Congress, Society of Critical Care Medicine, “Lipoproteins as therapeutic agents,” San Antonio, TX, January 28-February 2, 2003.

University of California, San Francisco, General Surgery Postgraduate Course, “Diagnosis and Staging of Acute Pancreatitis: Beyond the Ranson Criteria”, April 4, 2003, San Francisco, CA.

University of California, San Francisco, General Surgery Postgraduate Course, “Gallstone Pancreatitis”, April 5, 2003, San Francisco, CA.

Seventh Biennial Congress of the Asian Society of Hepato-biliary Pancreatic Surgery, “Summary review of pancreatic head resections at UCSF from 1990-2003,” Chennai, India, August 28-31, 2003.

Seventh Biennial Congress of the Asian Society of Hepato-biliary Pancreatic Surgery, “Surgical management of necrotizing pancreatitis,” Chennai, India, August 28-31, 2003.

University of California, San Francisco, Department of Surgery, “Pancreaticoduodenectomy: An Analysis of a Complex Procedure," December 3, 2003, San Francisco, CA.

International Sepsis Forum, “Triglyceride-rich Lipoproteins as Agents of Innate Immunity," June 1, 2004, Cambridge, England.

ASSA-SAGES 2004 Congress, “Recurrent pyogenic cholangitis,” Cape Town, South Africa, August 6-10, 2004.

ASSA-SAGES 2004 Congress, “The surgical management of necrotizing pancreatitis,” Cape Town, South Africa, August 6-10, 2004.

University of Witwatersrand, Department of Surgery, “Pancreaticoduodenectomy: indications and outcomes,” August 17, 2004, Johannesburg, South Africa.

Cho Ray Hospital, University of Medicine and Pharmacy at Hochiminh City, “Surgical management of necrotizing pancreatitis,” October 12, 2004, Hochiminh City, Vietnam.

First Open Laparoscopic and Endoscopic Congress, University of Medicine and Pharmacy at Hochiminh City and Hoan My Hospital, “Laparoscopic cystgastrostomy,” October 15, 2004, Hochiminh City, Vietnam.

Hoan My Hospital Da Nang, “Laparoscopic cystgastrostomy,” October 18, 2004, Da Nang, Vietnam.

University of California, San Francisco, Department of Surgery, “Exporting Surgical Excellence for Whipple Resection – Refinement of the Leapfrog Initiative," December 8, 2004, San Francisco, CA.

University of California, Davis-East Bay, Department of Surgery, “Surgical Disease of the Pancreas," January 13, 2005, Oakland, CA.

Sutter Delta Medical Center, “Pancreatic Cancer,” January 3, 2006, Antioch, CA.

University of California, Davis-East Bay, Department of Surgery, “Systemic Manifestations of Pancreatitis," February 2, 2006, Oakland, CA.

Alameda Hospital, “Abdominal Sepsis,” February 13, 2006, Alameda, CA.

Doctors Medical Center, “Acute Pancreatitis: Medical and Surgical Management,” February 15, 2006, Modesto, CA.

Pittsburgh Surgical Society, “ISIS: Lessons Learned from Egypt to Black Tar Heroin,” March 7, 2006, Pittsburgh, PA.

University of Pittsburgh, Department of Surgery, “Severe Acute Pancreatitis,” March 8, 2006, Pittsburgh, PA.

St. Rose Hospital, “Hepatobiliary Tumors: Benign Tumors of the Liver,” April 17, 2006, Hayward, CA.

Marin General Hospital, "Abdominal Sepsis," May 16, 2006, Marin, CA

Palm Drive Hospital, "Severe Acute Pancreatitis," May 17, 2006, Sebastopol, CA.

St. Joseph's Hospital of Stockton, "Abdominal Sepsis," October 17, 2006, Stockton, CA.

Sonoma Valley Hospital, "Severe Acute Pancreatitis," November 30, 2006, Sonoma, CA.

University of California, San Francisco, General Surgery Postgraduate Course, “Chronic Pancreatitis and Islet Autotransplantation”, March 22, 2007, San Francisco, CA.

University of California, San Francisco, Department of Surgery, “UCSF Surgical Hospitalist Program," April 25, 2007, San Francisco, CA.

Hershey Medical Center, Penn State University, "Triglyceride-rich Lipoproteins and Microbial Immunity," May 3, 2007, Hershey, PA.

West Virginia University Medical Center, Department of Surgery, "Lipoproteins and Microbial Immunity," August 15, 2007, Morgantown, WV.

Association for Academic Surgery, 18th Fundamentals of Scientific Research Course, "Nuts and Bolts of Scientific Writing," October 5, 2007, New Orleans, LA.

Surgical Biology Club I, "Apolipoprotein E and Microbial Immunity," October 7, 2007, New Orleans, LA.

Novato Community Hospital, "Gallstone Disease," November 5, 2007, Novato, CA.

University of California, San Francisco, Department of Surgery, “Lipoproteins & Microbial Immunity," March 26, 2008, San Francisco, CA.

University of California, San Francisco, General Surgery Postgraduate Course, “Intestinal Obstruction”, March 28, 2008, San Francisco, CA.

University of Kansas, Department of Surgery, "Surgical Management of Severe Acute Pancreatitis," May 20, 2008, Kansas City, KS.

University of California, San Francisco, General Surgery Postgraduate Course, “Evolution of Hernia Mesh”, March 19, 2009, San Francisco, CA.

University of California, San Francisco, General Surgery Postgraduate Course, “Complex Ventral Hernia Repair”, March 19, 2009, San Francisco, CA.

University of California, San Francisco, “African American Health Disparities,” September 16, 2008, San Francisco, CA.

University of California, San Francisco, General Surgery Postgraduate Course, “Complex Ventral Hernias”, April 30, 2010, San Francisco, CA.

San Francisco General Hospital Department of Surgery, Grand Rounds, “HPB Surgery at SFGH,” February 16, 2011, San Francisco, CA.

University of California, San Francisco, General Surgery Postgraduate Course, “Postoperative Ileus”, March 20, 2011, Maui, HI.

University of California, San Francisco, General Surgery Postgraduate Course, “Acute Renal Failure; Management Update”, March 20, 2011, Maui, HI.

University of California, San Francisco, General Surgery Postgraduate Course, “Acute Appendicitis; What’s New with and Old Foe”, March 21, 2011, Maui, HI.

University of California, San Francisco, General Surgery Postgraduate Course, “Enterocutaneous Fistulas,” March 21, 2011, Maui, HI.

University of California, San Francisco, General Surgery Postgraduate Course, “Open Ventral Hernia Repair,” March 21, 2011, Maui, HI.

University of California, San Francisco, General Surgery Postgraduate Course, “Severe Acute Pancreatitis,” March 22, 2011, Maui, HI.

University of California, Davis-East Bay, Department of Surgery, “Surgical Response to the Surviving Sepsis Campaign," July 21, 2011, Oakland, CA.

American College of Surgeons, panelist, “Maximizing the Future of Surgical Leadership.” October 24, 2011, San Francisco, CA.

Sixtieth Annual Meeting of the Louisiana Chapter of the American College of Surgeons and Surgical Association of Louisiana, “Enterocutaneous Fistulas,” January 21, 2012, New Orleans, LA.

East Bay Surgical Society, “Complex Ventral Hernias,” February 9, 2012, Oakland, CA.

University of California, San Francisco, General Surgery Postgraduate Course, “Early Goal Directed Therapy: Surviving Sepsis”, March 25, 2012, Oahu, HI.

University of California, San Francisco, General Surgery Postgraduate Course, “Negative Wound Pressure Therapy”, March 26, 2012, Oahu, HI.

University of California, San Francisco, General Surgery Postgraduate Course, “Ventral Hernia Repair: the Prosthetic Jungle”, March 26, 2012, Oahu, HI.

University of California, San Francisco, General Surgery Postgraduate Course, “Massive Ventral Hernias,” March 26, 2012, Oahu, HI.

Tulane University School of Medicine, Department of Surgery Grand Rounds, “Management of Severe Acute Pancreatitis,” June 1, 2012, New Orleans, LA.

University of California, San Francisco, General Surgery Postgraduate Course, “Human Microbiome and Surgery”, March 24, 2013, Kauai, HI.

University of California, San Francisco, General Surgery Postgraduate Course, “Biologic Prosthetics and Beyond”, March 25, 2013, Kauai, HI.

University of California, San Francisco, General Surgery Postgraduate Course, “Emerging Concepts in Ventral Hernia Repair”, March 25, 2013, Kauai, HI.

University of California, San Francisco, General Surgery Postgraduate Course, “Surgical Management of Severe Acute Pancreatitis”, March 26, 2013, Kauai, HI.

Royal Australasian College of Surgeons 82nd Annual Scientific Congress, “Incisional Hernias – From Simple to Complex”, May 7, 2013, Auckland, New Zealand.

Royal Australasian College of Surgeons 82nd Annual Scientific Congress, “The Challenge of Abdominal Trauma in the Obese Patient”, May 8, 2013, Auckland, New Zealand.

Royal Australasian College of Surgeons 82nd Annual Scientific Congress, “Acute Pancreatitis – an American Perspective”, May 8, 2013, Auckland, New Zealand.

Royal Australasian College of Surgeons 82nd Annual Scientific Congress, “Iatrogenic Bile Duct Injury”, May 9, 2013, Auckland, New Zealand.

University of California, San Francisco, General Surgery Postgraduate Course, “Surgical Management of Severe Acute Pancreatitis”, May 17, 2013, San Francisco, CA.

University of California, San Francisco, General Surgery Postgraduate Course, “Biologic Prosthetics and Beyond”, May 18, 2013, San Francisco, CA.

University of California, San Francisco, General Surgery Postgraduate Course, “Emerging Concepts in Ventral Hernia Repair”, May 18, 2013, San Francisco, CA.

UCSF Naffziger Post Graduate Course, May 17-18, 2013, San Francisco, CA.

4th Annual Women in Surgery Career Symposium, June 7-9, 2013, San Francisco, CA

University of California, San Francisco, Department of Surgery, “Sensors for wound healing and hernia repair," June 3, 2015, San Francisco, CA.

SAGES 2016 Surgical Spring Week, “Debate: Con-Robot Herniorrhaphy,” March 17, 2016, Boston, MA.

International Symposium on Incisional Hernia Prevention, “Myoseal: enhanced myofascial wound healing,” October 20, 2017, San Francisco, CA.

Second Research Symposium on Incisional Hernia Prevention, “Myoseal: enhanced myofascial wound healing,” November 30, 2017, Barcelona, Spain.

Korle Bu Teaching Hospital, Department of Surgery, “Incisional hernia management and prevention,” Thursday, February 22, 2018, Accra, Ghana.

Korle Bu Teaching Hospital, Department of Surgery, “Incisional hernia prevention,” Friday, February 23, 2018, Accra, Ghana.

International Hernia Congress, “Infiltrating research funding: a guide to grant funding from local sources to the NIH,” March 13, 2017, Miami, FL.

International Hernia Congress, “Hernia prevention and management: what is important to patients?” March 14, 2017, Miami, FL.

41st Annual International Congress of the European Hernia Society, “Preventing recurrence in clean and contaminated hernias (PRICE): a randomized trial of biologic versus synthetic mesh in ventral hernia repair.” September 13, 2019, Hamburg, Germany.

Americas Hernia Society 2020 Meeting – moderated Q&A Session moderator, recorded September 10, 2020. (virtual)

European Colorectal Congress, “Incisional Hernia Prevention Virtual Roundtable,” November 30 – December 2, 2020. (virtual)

International Journal of Abdominal Wall and Hernia Surgery 2020 Annual Meeting, “Preventing recurrence in clean and contaminated hernias (PRICE): a randomized trial of biologic versus synthetic mesh in ventral hernia repair.” December 11-12, 2020. (virtual)

University of Florida, Department of Surgery Grand Rounds, “Biologic Mesh for Ventral Hernia Repair: A Cautionary Tale.” January 22, 2021. (virtual)

University of Houston, Department of Surgery Grand Rounds, “Prevention of Incisional Hernias.” March 3, 2021. (virtual)

Hernia 360 by Medtronic, “Incisional Hernia Prevention in Colorectal Surgery – Meet the Experts,” March 4, 2021. (virtual)

Cleveland Clinic, Department of General Surgery Grand Rounds, “Prevention of Incisional Hernias.” September 1, 2021. (virtual)

2021 International Symposium on Incisional Hernia Prevention, Oct 2, 2021 (organizer, moderator & speaker; virtual)

2021 International Symposium on Incisional Hernia Prevention (organizer, moderator & speaker), October 2, 2021 (virtual)

Creighton Phoenix, Department of Surgery Grand Rounds. “Biologic mesh for ventral hernia repair: a cautionary tale.” April 12, 2022, Phoenix, AZ.

2022 American Society of Colon and Rectal Surgeons (ASCRS) Annual Scientific Meeting, “’To Keep in or Take Out:’ Managing Mesh in an Infected Abdomen.” May 1, 2022, Tampa, FL.

2022 Association of Surgeons of Great Britain and Ireland Congress, “Managing Complications in AWR.” May 3, Liverpool, England.

International Incisional Hernia Prevention Symposium, “The Future of Incisional Hernia Prophylaxis – Politics, Patients and Innovation.” May 6, 2022, Cardiff, Wales.

Butsch Memorial Lectureship Residents Conference, University at Buffalo, Department of Surgery. “Biologic mesh for ventral hernia repair: a cautionary tale.” September 9, 2022, Buffalo, NY.

Winfield L. Butsch Memorial Lecture, Department of Surgery Grand Rounds. “Incisional Hernia Prevention: Stop the Bulge.” September 10, 2022, Buffalo, NY.

American Hernia Society 2022 Meeting, “Hernia prevention through improved wound healing” September 15, 2022, Charlotte, NC.

NYU Langone Medical Center, “T-Line mesh: an innovation in ventral hernia repair.” January 24, 2023, New York, NY.

American Hernia Society 2023 Meeting, “Incisional hernia prevention through enhanced wound healing.” September 22, 2023, Austin, TX

2nd International Symposium on Incisional Hernia Prevention, Oct 6-7, 2023 (organizer, program chair, and moderator), San Francisco, CA.

2nd International Symposium on Incisional Hernia Prevention, “MYOSEAL: hernia prevention through improved wound healing,” October 7, 2023, San Francisco, CA.

American Hernia Society 2024 Meeting, “Abdominal wall closure with a novel suture tension distribution device after oncologic laparotomy” September 12, 2024, Chicago, IL.

American Hernia Society 2024 Meeting, “A review of quality-of-life grading scales.” September 13, 2024, Chicago, IL.

UNIVERSITY SERVICE:

Department

1994 - 2019              Research Committee

1994 - 2017              Admissions Committee

1994 - 1997              Surgical Lab Director Search Committee, San Francisco General Hospital

1995 - present              Surgical Education Committee

2000 - 2017              Resident Recruitment Committee

2004 - 2019              Merit and Promotions Committee

2006 - 2017              Faculty Mentoring Facilitator

2009 - 2021              Chief, Red Surgery Service, UCSF

2012 - 2017              Surgical Quality Improvement Committee

2012 - 2021              Program Director, NIH T32 Training Program in Gastrointestinal Surgery

2013 - 2014              Chair, Surgical Oncology Search Committee

2018              Co-Chair, Surgery-Critical Care Task Force

2019 - 2020              Chair, New Technologies Committee

2019              Member, Chief of Cardiothoracic Surgery Search Committee

2019              Chair, Acute Care Surgeon Search Committee

2019              Member, Vice Chair of Education Search Committee

School of Medicine

2000 - 2003              Equal Opportunity Committee

2001 - 2003              Chancellor's Advisory Committee on Diversity

2002 - 2004              Contracting Committee, Co-Chair, UCSF Medical Group

2002 - 2010              Medical School Admissions Committee

2002 - 2005              UCSF Cancer Center Executive Committee

2003 - 2007              Critical Players at Mt. Zion Medical Center

2004 - 2006              Clinical Affairs Committee

2004 - 2011              Task Force on Underrepresented Minorities

2004 - present              Academic Standards Committee

2005 - 2007              Clinical Products Standard Committee

2006 - 2010              Faculty Mentoring Program, Department of Surgery Representative

2006 - 2015              UCSF Healthcare Technology Assessment Program

2007 - 2008              Chancellor’s Advisory Committee on Academic Diversity, Steering Committee

2008 - 2010              Chair, Equal Opportunity Committee

2008 - 2012              Student Research Review Committee

2008              School of Medicine Stewardship Review Committee

2009 - 2012              Chancellor’s Advisory Committee on Academic Diversity

2011 - 2017              Chair, Academic Standards Committee

2013 - 2014              School of Medicine Space Committee

2013 - 2014              CSB/UCH Renovation Faculty Advisory Committee

2013 - 2019              UCSF, Biologic & Synthetic Mesh Sub-Committee

2015 - 2017              Dean’s Diversity Committee

2019 - 2022              Standing Panel for Faculty Misconduct Investigations

Other

1995 - 2001              Advisory Committee, General Clinical Research Center, San Francisco General                                           Hospital

1995 - 1996              Interventional Radiologist Search Committee, San Francisco General Hospital

1995 - 1996              Minimally Invasive Surgery Committee, San Francisco General Hospital

1996 - 1999              Co-Chairman, General Surgery Section, Program Planning Committee,

                                          Northern California Chapter, American College of Surgeons

1996 - 1997              Research Committee, San Francisco General Hospital

1996 - 1997              Tissue Committee, San Francisco General Hospital

1997 - 1998              Thoracic/CT Radiologist Search Committee, San Francisco General Hospital

1997 - 1998              Cardiology Search Committee, San Francisco General Hospital

1997 - 2001              Co-Chairman, Cancer Committee, San Francisco General Hospital

2000 - 2001               Co-Medical Director, Integrated Soft Tissue Infection Service (ISIS), SFGH

2001 - 2002               Chief of General Surgery Search Committee, UCSF

2003              Chief of Surgery, San Francisco VA Medical Center, Chair of Search Committee

2004 - 2006              Capacity Solutions Committee, UCSF Medical Center

2007              Director of Academic Diversity, Search Committee

2009              Chief, Division of Gastrointestinal Medicine Search Committee, UCSF

FORMAL SCHEDULED CLASSES FOR UCSF STUDENTS

Date                                                                                                                                                                        Class              Hours

Taught              Course No. & Title                            Nature of Contribution                                          Size              per yr.

1994 - 2014              Surgery 110:  Core              Take students on rounds and discuss cases.              4-8              100

              Clinical Surgery Clerkship.              Instruction in physical diagnosis and treatment.

1996 - 2009              Medicine 111:              “Fluid Management” (invited lecturer)                            140              1.5

1997 - 2003              Medicine 111:              “Surgical Emergencies” (invited lecturer)                            140              1.5

1999 - 2003              Medicine 111:              "Acute Pancreatitis" (invited lecturer)                            140              1.5

2003 - 2009              Medicine 111:              "Abdominal Emergencies" (invited lecturer)              140              3.0

HOUSE STAFF & FELLOWS

1994 - present              400.  General Surgical                            Conferences, case presentations, guest              15              40/yr.

                                          Conference, lectures, death and complication discussions.

1994 - present              490.  Clinical Surgery                            Resident teaching and supervision of               2-4              140/yr.

                                          pre-op, operative and post-op patients

1994 - 2017              Research                            meetings, lectures, data analysis                            1-2              150/yr.

GROUP INSTRUCTION                            HOURS/YEAR              FROM-TO                            DIRECTOR

G.I. Conference                                                        48                            1994-2002                            John Cello, M.D.

SFGH Complications                                                        75                            1994-2002                            William Schecter, M.D.

Basic Science Course                                                        02                            1994-2014                            Ryo Hirose, M.D.

G.I. Radiology Conference                                          48                            1997-2002                            Ernest Ring, M.D.

Tumor Board                                                                      12                            1998-2001                            Judy Luce, M.D.

General Surgery (White) Conference                            48                            2002-2003                            Robert Warren, M.D.

General Surgery (Blue) Conference                            48                            2003-2005                            Lawrence Way, M.D.

General Surgery (Red) Conference                            48                            2005-present                            Jonathan Carter, M.D.

GI Radiology Conference                                          24                            2012-2018                            Robert Kerlan, M.D.

Informal Teaching:

1994 - now                            Surgical Attending                            Discuss cases with residents.                                          200/yr.

                                                                                                  Teach residents in operating room and clinic.

Postdoctoral Scholars Supervised

1.)              Guoshon Su, MD (July 1, 1995 - June 30, 1996)

2.)              Shyr-Ming Sheen-Chen, MD (July 1, 1996 - June 30, 1998)

3.)              Zindaba L. Kumwenda, MD (July 1, 1997 – June 30, 2001)

4.)              Jessica Gosnell, MD (July 1, 1998 - 2000)

5.)              Brian O. O'Neill, MD (July 1, 1999 - June, 2001)

6.)              Qiang Liu, MD (July 1, 1999 - June, 2001)

7.)              Behzad Kasravi, MD, PhD (May 1, 2000 - June 30, 2007)

8.)                Ines Verdon (July 1, 2001 - December 31, 2001)

9.)                Austin Spitzer, MD (July 1, 2003 - June 30, 2005)

10.)            Michael Schell, MD (July 1, 2002 - June 30, 2005)

11.)            Stephen Dada, MD (July 1, 2004 - June 30, 2005)

12.)            Kelley Chuang, MD (July 1, 2008 - June 30, 2010)

13.)            Ian Brown, MD, PhD (July 1, 2010 – June 30, 2012)

14.)            Natalie Seiser, MD, PhD (July 1, 2010 – June 30, 2012)

15.)            Frank Primus, MD (July 1, 2010 – June 30, 2013)

16.)            Carolyn Seib, MD (July 1, 2012 – June 30, 2014)

17.)            Xiato Xu, MD (July 1, 2013 – June 30, 2014)

18.)            Chetan Irwin, MD (July 1-2013 – June 30, 2014)

19.)            Victoria Lyo, MD (July 1, 2014 – June 2016)

20.)            Tammy T. Chang, MD, PhD (January 2011 - 2016)

21.)            Jennifer Rose-Nussbaumer, MD (July 1, 2014 - 2019)

22.)            Carter Lebares, MD (July 2015 – June 2017)

23.)            Juliet Okoroh, MD (July 2017 – June 2018)

24.)            Nichole Starr, MD (July 2018 -June 2020)

25.)            Caitlin Collins, MD (July 2018 - June 2020)

26.)            Keith Hansen, MD (July 2021 – June 2022)

Graduate Students Supervised

1.)                Brian Kearney, PharmD (January, 1998--1999)

2.)                Hiwot Woldeseymayat (September 15, 2011 – June 30, 2014)

3.)                Amy Liao (April 2014 - May 2018)

Students Supervised

1.)                Amish Shah (June-August, 1995)

2.)                Rhawah Ghermay (June-August, 1996)

3.)                Andrew Ngyuen (June-August, 1998)

4.)                Crystal Carpino (June-August, 1998; June-August, 2000)

5.)                Tina Chen (June-August, 2001)

6.)                Jesus Lozano (June-August, 2002)

7.)                Anthony Barcia (July 1, 2002-June 1, 2005)

8.)                Rita A. Mukhtar (May 1, 2004-May 1, 2006)

9.)                Lorenzo Machado (June 27, 2005-August 19, 2005)

10.)            Marcus Zachariah (June 27, 2005-August 19, 2005)

11.)            Ezechinyerem Uzosike (Summer 2007)

12.)            Jill Tseng (Summer 2007)

13.)            Arjun Bannerjee (Summer 2008 & 2009)

14.)            Naftali Presser (Summer 2008)

15.)            Nancy Hsu (Summer 2008 & 2009)

16.)            Alexandra Shawo (2008 - 2010)

17.)            Benjamin Rayikanti (Summer 2011, 2012, 2013, and 2015)

18.)            Oliver Bellevue (June 2011 – May 2014)

19.)            Jenette Haerptyan (October 2012 – August 2014)

20.)            Samuel Zetumer (July 2016 – June 2017)

NON-UNIVERSITY ACTIVITIES:

1994 - present              Ad Hoc reviewer, JAMA Surgery, Critical Care Medicine, Digestion, Digestive Diseases and Science, Hepatology, Indian Journal of Surgery, Journal of the American College of Surgeons, Journal of the American Medical Association, Journal of Clinical Investigation, Journal of Gastroenterology and Hepatology, Journal of Infectious Diseases, Pharmacology and Toxicology, Surgery and Clinical Infectious Diseases.

1995 - 1998              Section Editor, General Surgery for Advances in Gastroenterology, Hepatology, and Clinical Nutrition

2000 - 2001              Program Director, San Francisco Surgical Society

2001 - 2003              Councilor, Association for Academic Surgery

2001 - 2008              Committee on Applicants, Northern California Chapter, American College of Surgeons

2001 - 2004              Secretary-Treasurer, Northern California Chapter, American College of Surgeons

2002 - 2006              Editorial Board, Journal of Surgical Research

2003 - 2006              Membership Committee, Surgical Infection Society

2003 - present              Member, Research Advisory Board, Shriners Hospitals for Children

2004              President-elect, Northern California Chapter, American College of Surgeons

2004 - 2005              Secretary-Treasurer, San Francisco Surgical Society

2005              President, Northern California Chapter, American College of Surgeons

2005 - 2008              Clinical Councilor, Shock Society

2005 - 2008              Member, Program Committee, American HepatoPancreaticoBililary

2006 - 2008              Governor-at-Large from California, American College of Surgeons

2006 - 2018              Associate Editor, HPB Surgery

2007 - 2009              Program Committee, Surgical Infection Society

2007 - 2008              Co-Chair, Research Advisory Board, Shriners Hospitals for Children

2008 - present              Chair, Research Advisory Board, Shriners Hospitals for Children

2008 - 2017              Chair, Burns Subcommittee, Shriners Hospitals for Children

2011 - 2013              Member, Program Committee, Society for Surgery of the Alimentary Tract

2011 - 2020              Editorial Board, Shock

2017 - present              Member, Hernia Prevention Task Force, Americas Hernia Society

2017              Organizer & Chair, International Symposium on Incisional Hernia Prevention

2018 - 2021              Chair, Membership Committee, Americas Hernia Society

2018 - present              Governor & Member, Board of Directors, Americas Hernia Society

2019 - present              Associate Editor, International Journal of Abdominal Wall and Hernia Surgery

2023 – 2024              Member, Residents and Fellows Committee, Americas Hernia Society

MEMBERSHIP ON FEDERAL GOVERNMENT PUBLIC ADVISORY COMMITTEES:

2000              Member, Special Emphasis Panel ZGM1 PPBC, NIH-NIGMS

2002              Chair, Special Emphasis Panel ZGM1 PPBC, NIH-NIGMS

2003              Member, Special Emphasis Panel ZGM1 TB-6 (03)(P), NIH-NIGMS

2004              Chair, Special Emphasis Panel ZRG1 IDM-N (90), NIH-NIGMS

2004              Member, Special Emphasis Panel ZGM1 TB-5 (3P), NIH-NIGMS

2005 (Mar)              Member, Special Emphasis Panel ZGM1 PPBC-5 (TB), NIH-NIGMS

2005 (Nov)              Chair, Special Emphasis Panel ZGM1 PPBC-5 (TB), NIH-NIGMS

2006              Chair, Special Emphasis Panel ZGM1 PPBC-5 (TB), NIH-NIGMS

2006              Member, Special Emphasis Panel ZGM1 BRT-1 (LR), NIH-NIGMS

2006 - 2007              Ad Hoc member, Surgery, Anesthesiology & Trauma Study Section, NIH-NIGMS

2007 - 2011              Member, Surgery, Anesthesiology & Trauma Study Section, NIH-NIGMS

2007              Reviewer, National Institutes of Health Director's Pioneer Awards

2007              Reviewer, National Institutes of Health Director's New Innovator Awards

2008              Reviewer, National Institutes of Health Director's Pioneer Awards

2008              Reviewer, National Institutes of Health Director's New Innovator Awards

2009              Chair, Special Emphasis Panel ZGM1 PPBC-5 (TB), NIH-NIGMS

2010              Chair, Special Emphasis Panel ZGM1 PPBC-5 (BN), NIH-NIGMS

2011              Consultant, General and Plastic Surgery Devices Panel, Federal Drug Administration

2011              Consultant, Medical Devices Advisory Committee, Federal Drug Administration

2011              Consultant, Center for Devices and Radiological Health

2011              Reviewer, National Institutes of Health Director's Pioneer Awards

2012              Reviewer, National Institutes of Health Director's Pioneer Awards

2013 - 2015              Chair, NIH, Surgery, Anesthesiology & Trauma Study Section, Center for Scientific Review, Chair

2013 - 2022              FDA, LCDR, US Public Health Service, Center for Devices and Radiological Health, General and Plastic Surgery Devices Advisory Committee consultant.

2015              Reviewer, National Institutes of Health Director's Pioneer Awards

2016              Acting Chair, FDA Center for Devices and Radiological Health, General and Plastic Surgery Devices Review Division, General and Plastic Surgery Devices Advisory Committee

2020              FDA, LCDR, US Public Health Service, Center for Devices and Radiological Health, Orthopedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee Meeting, virtual, September 9, 2020.

2022 - present              FDA Center for Devices and Radiological Health, General and Plastic Surgery Devices Review Division, General and Plastic Surgery Devices Advisory Committee member.

2022 - present              Chair, FDA Center for Devices and Radiological Health, General and Plastic Surgery Devices Review Division, General and Plastic Surgery Devices Advisory Committee.

2022              FDA Center for Devices and Radiological Health, General and Plastic Surgery Devices Review Division, General and Plastic Surgery Devices Advisory Committee Meeting;
Recommendations about the reclassification of skin lesion analyzers, July 28-29, 2022.

2022              FDA Center for Devices and Radiological Health, General and Plastic Surgery Devices Review Division, General and Plastic Surgery Devices Advisory Committee Meeting; Discuss and make recommendations on the classification proposals for tissue expanders and accessories, mammary sizers, wound dressings with animal-derived materials, absorbable synthetic wound dressings, and hemostatic wound dressings with or without thrombin, nail prostheses, ultrasonic surgical instruments, single-use reprocessed ultrasonic surgical instruments, and neurosurgical ultrasonic instruments, October 26-27, 2022.

2024              FDA Center for Devices and Radiological Health, General and Plastic Surgery Devices Review Division, General and Plastic Surgery Devices Advisory Committee Meeting; Recommendations regarding approval of the Prosense cryoablation device for the treatment of early stage, low-risk breast cancer, November 7, 2024.

PAST RESEARCH EXPERIENCE:

1978 - 1979:              Senior Honors Thesis; under the auspices of Dr. John Hedley-Whyte, Chairman of the Anesthesia, Department, Beth Israel Hospital, Boston, MA.  “Effect of Morphine Sulphate on the Metabolism of 2-deoxy-D-glucose in Rat Brain”.

1982 - 1984:              Honors Thesis in a Special Field; under the director of Dr. Kenneth C. Hayes, Chairman, Biochemistry Department, Brandeis University, Boston, MA, and Dr. Michael Stemerman, Department of Medicine, Beth Israel Hospital, Boston, MA.  “Atherogenesis and the Effects of Dietary lipid on Platelet Function in Nonhuman Primates”.

1987 - 1991:               Research Fellowship, under the direction of Drs. John P. Kane and Joseph H. Rapp, Cardiovascular Research Institute, University of California, San Francisco.  “The Role of Postprandial Lipoproteins and the Liver in Sepsis”.

CURRENT RESEARCH:

Examination of the cellular response to acute injury and repair with a focus on i) management and prevention of incisional hernias and ii) effect of metallic silver and fibrin on wound healing.

PUBLICATIONS:

PEER-REVIEW ARTICLES

1. Harris HW, Rapp JH, Kunitake ST, Krupski WC, Kane JP.  Modified low-density lipoprotein isolated from fresh human atherosclerotic plaque.  Surgical Forum 1988; 39:319-21.
2. Rapp JH, Harris HW, Hamilton RL, Krupski WC, Reilly LM, Ehrenfeld WK, Stoney RJ, Goldstone J and Kane JP.  Particle size distribution of lipoproteins from human atherosclerotic plaque:  A preliminary report.  J Vasc Surg 1989; 4:81-88.
3. Pan XM, Rapp JH, Harris HW, Krupski WC, Hale JD, Sheldon P and Kaufman L.  Identification of aortic thrombus by magnetic resonance imaging.  J Vasc Surg 1989; 9:801-805.
4. Harris HW, Rapp JH, Reilly LM, Orlando PA, Krupski WC and Goldstone J.  Saphenous vein bypass to pedal arteries.  Arch Surg 1980; 124:1232-1236.
5. Harris HW, Grunfeld C, Feingold KR and Rapp JH.  Human VLDL and chylomicrons can protect against endotoxin-induced death in mice.  J Clin Invest 1990; 86:696-702.
6. Eichbaum EB, Harris HW, Kane JP and Rapp JH.  Chylomicrons can inhibit endotoxin activity in vitro.  J Surg Res 1991; 51:413-416.
7. Harris HW, Eichbaum EB, Kane JP and Rapp JH.  Detection of endotoxin in triglyceride-rich lipoproteins in vitro.  J Lab Clin Med 1991; 118:186-193.
8. Read TE, Harris HW, Grunfeld C, Feingold KR, Kane JP and Rapp JH.  The protective effect of serum lipoproteins against bacterial lipopolysaccharide.  European Heart J 1993; 14 Suppl:K:125-129.
9. Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP, Jones AL, Eichbaum EB, Bland GF and Rapp JH.  Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death.  J Clin Invest 1993; 91:1028-1034.
10. Read TE, Harris HW, Grunfeld C, Feingold KR, Calhoun MC, Kane JP and Rapp JH.  Chylomicron binding increases endotoxin excretion in bile.  Infection and Immunity 1993; 61:3496-3502.
11. Emond J, Wachs ME, Renz JF, Kelley S, Harris H, Roberts JP, Ascher NL, Lim RC.  Total vascular exclusion for major hepatectomy in patients with abnormal liver parenchyma.  Arch Surg 1995; 130:824-831.
12. Sperling RM, Koch J, Harris H, Sandhu FS and Cello JP.  Natural history of recurrent pyogenic cholangitis in Asian immigrants to the US.  Gastrointest Endo 1995; 41:417.
13. Ghermay AP, Brady S, Havel R, Harris HW and Rapp JH.  Sepsis increases endocytosis of endotoxin by hepatocytes.  Surgery 1996; 120:389-93.
14. Harris HW, Rockey DC, Chau PL, Kane JP and Rapp JH.  Effect of chylomicrons on the clearance of endotoxin by hepatocytes.  Surg Forum 1996; 47:10-11.
15. Harris HW, Chau PL, Kane JP and Rapp JH.  Endogenous hypertriglyceridemia protects against endotoxemia in rats.  J Endotoxin Res 1996; 3:26.
16. Hojman H, Lounsbury D, Harris H and Horn J.  Immunodepressive effects of LPS on monocyte CD14 in vivo.  J Surg Res 1997; 69:7-10.
17. Harris HW.  Fasting and postprandial lipoproteins abrogate the effects of endotoxin in humans.  Shock 1997; 7 Suppl 1:24.
18. Horn JK, Hojman H, Lounsbury D and Harris HW.  Induction of human leukocyte apoptosis and phenotypic alterations by LPS infusion into volunteers: 452. Shock 1997;7 Suppl 1:114.
19. Sheen-Chen SM, Chau PL, and Harris HW.  Altered Kupffer cell function in obstructive jaundice occurs independent of bacterial translocation.  Surg Forum 1997; 48:191-193.
20. Harris HW.  Lipoproteins can ameliorate the effects of endotoxemia in humans.  Surgical Forum 1997; 48:70-72.
21. Glasgow RE, Visser BC, Harris HW, Patti MG, Kilpatrick SJ and Mulvihill SJ.  Changing management of gallstone disease during pregnancy.  Surg Endo 1998; 12:241-246.
22. Harris HW, Schecter WP. Surgical risk assessment and management in patients with HIV disease. Gastroenterol Clin North Am. 1997; 26:377-91.
23. Harris HW.  Endoscopic pancreatic debridement (invited commentary).  Adv Gastro Hepatol Clin Nutr 1998;3:126-128.
24. Gantert W and Harris HW.  Laparoscopic paraesophageal hernia repair: a new standard.  (invited commentary)  Adv Gastro Hepatol Clin Nutr 1998;3:457-459.
25. Kang L and Harris HW.  Antibiotic prophylaxis in acute pancreatitis.  Adv Gastro Hepatol Clin Nutr 1998;3:230-238.
26. Harris HW, Rockey DC, and Chau P.  Chylomicrons alter the hepatic distribution and cellular response to endotoxin in rats.  Hepatology 1998; 27:1341-1348.
27. Harris HW, Kunwenda ZL, Sheen-Chen SM, Shah A, and Schecter WP.  Recurrent pyogenic cholangitis. Am J Surg 1998; 176:34-37.
28. Kumwenda ZL, Welch WJ, and Harris HW.  Chylomicron-bound endotoxin inhibits hepatocellular nitric oxide production by inhibiting nuclear factor B activation in rats.  Surg Forum 1998; 49:8-9.
29. Sheen-Chen SM, Chau P, and Harris HW.  Kupffer cell function is altered in obstructive jaundice independent of bacterial translocation. J Surg Res 1998; 80:205-209.
30. Harris HW, Rockey DC, Young DM, and Welch WJ.  Diet-induced protection against LPS includes increased hepatic NO production.  J Surg Res 1999; 82:339-345.
31. Harris HW, Morabito D, Mackersie RC, Halvorsen RA and Schecter WP.  Leukocytosis and free fluid are important indicators of isolated occult intestinal injury following blunt trauma.  J Trauma 1999; 46:656-659.
32. Kumwenda ZL, Welch WJ, and Harris HW.  Chylomicron-bound endotoxin selectively inhibits nuclear transcription factor-B activation in rat hepatocytes.  Surg Forum 1999; 50:213-215.
33. Gosnell JE, Welch WJ, and Harris HW.  The extracellular matrix regulates the hepatocellular stress response.  Surg Forum 1999; 50:10-11.
34. Gosnell JE, Wong CB, Welch WJ and Harris HW.  The extracellular matrix can regulate the hepatocellular response to cytokines.  J Surg Res 2000; 91:43-49.
35. O'Neill BO, Gosnell JE, Lull RJ, Koch J, Halverson RJ, Schecter WP and Harris HW.  Cinematic nuclear scintigraphy reliably directs surgical intervention in patients with gastrointestinal bleeding.  Arch Surg 2000; 135:1076-1082.
36. Gosnell JE, Welch WJ and Harris HW.  Heat shock inhibits the acute phase response in primary rat hepatocytes.  Curr Surg 2000; 57:637.
37. O'Neill BB, Sheen-Chen SM, Welch WJ and Harris HW.  Systemic heat shock attenuates the neuroendocrine response to surgical stress in rats.  J Surg Res 2000; 93:315.
38. Liu Q, Fischer H, Welch WJ and Harris HW.  Cerulein-induced acute pancreatitis is more severe in mice heterozygous for the F508 cystic fibrosis transmembrane conductance regulator gene mutation than wild-type controls.  J Surg Res 2000; 93:317-18.
39. Harris HW, Gosnell JE and Kumwenda ZL.  The lipemia of sepsis: triglyceride-rich lipoproteins as agents of innate immunity.  J Endotoxin Res 2001; 6:421-430.
40. Ciccarone D, Bamberger JD, Kral AH, Edlin BR, Hobart CJ, Moon A, Murphy EL, Bourgois P, Harris HW and Young DM.  Soft tissue infections among injection drug users-San Francisco, California, 1996-2000.  MMWR 2001; 50:381-384.
41. Ciccarone D, Bamberger JD, Kral AH, Edlin BR, Hobart CJ, Moon A, Murphy EL, Bourgois P, Harris HW and Young DM.  Soft tissue infections among injection drug users-San Francisco, California, 1996-2000.  JAMA 2001; 285:2707-2709.
42. Johnson JA, Welch WJ and Harris HW.  Heat shock inhibits NF-kB activation in a transient and dose-dependent manner.  Shock 2001; 15 Suppl 1: Abstracts 37.
43. Gosnell JE and Harris HW.  Necrotizing pancreatitis during pregnancy: a case report and review of the literature. J Gastrointestinal Surg 2001;5:371-376.
44. Gosnell JE, Welch WJ and Harris HW.  Prior heat shock treatment attenuates the acute phase response in primary rat hepatocytes.  Crit Care Med 2001; 12 (Suppl Abstracts):A59.
45. Harris HW, Johnson JA and Wigmore SJ.  Endogenous lipoproteins impact the response to endotoxin in humans. Crit Care Med 2002; 30:23-31.
46. Kumwenda ZL, Wong CB, Johnson JA, Gosnell JE, Welch WJ, and Harris HW.  Chylomicron-bound endotoxin selectively inhibits NF-B activation in rat hepatocytes. Shock 2002;18:182-188.
47. Harris HW, Brady SE and Rapp JH.  Endosomal trafficking of lipoprotein-bound endotoxin in rats. J Surg Res 2002;106:188-95.
48. Kasravi FB and Harris HW.  Apolipoprotein E isoforms predict the hepatic response to sepsis. J Am Coll Surg 2002;195:S88.
49. Kasravi FB and Harris HW.  Internalization of lipoprotein-bound LPS induces tolerance to cytokines in rat hepatocytes.  J Surg Res 2002;107:324.
50. Harris HW and Young DM.  Care of Injection Drug Users with Soft Tissue Infections in San Francisco.  Arch Surg 2002;137:1217-22.
51. Kasravi FB, Welch WJ, Peters-Lideu CA, Weisgraber KH and Harris HW.  Induction of cytokine tolerance in rodent hepatocytes by chylomicron-bound LPS is LDL receptor dependent.  Shock 2003;19:157-162.
52. Harris HW and Kasravi FB.  Lipoprotein-bound LPS induces cytokine tolerance in hepatocytes.  J Endotoxin Res 2003; 9:45-50.
53. Miller G, Schecter WP and Harris HW.  Gallbladder ascariasis in a patient with severe pancreatitis. Surgery 2003; 133:445-46.
54. Kasravi FB, Brecht WJ, Weisgraber KH and Harris HW.  Induction of cytokine tolerance requires internalization of chylomicron-bound LPS into hepatocytes.  J Surg Res 2003;115:303-309.
55. Harris HW, Barcia A, Schell MT, Thoeni RF, and Schecter WP.  Necrotizing pancreatitis: a surgical approach independent of documented infection.  HPB 2004;6:161-168.
56. Young DM, Harris HW, Charlebois ED, Chambers H, Campbell A, Perdreau-Remington F, Lee C, Mankani M, Mackersie R and Schecter WP.  An epidemic of methicillin-resistant Staphylococcus aureus soft tissue infections among medically underserved patients.  Arch Surg 2004;139:947-953.
57. Kasravi FB, Lee DH, Weisgraber KH and Harris HW.  Lipoprotein-bound endotoxin exerts an immunomodulatory effect on hepatocytes through the lipid A domain of LPS.  J Endotoxin Res 2005;11:19-24.
58. Mukhtar RA, Kasravi FB and Harris HW. Chylomicron-lipotechoic acid complexes induce cytokine tolerance in primary rat hepatocytes. Surg Infect 2005;6:161.
59. Davis BR, Vitale GC and Harris H.  The evolution of endoscopy: wireless capsule cameras for the diagnosis of occult gastrointestinal bleeding and inflammatory bowel disease.  Surg Innov 2005;12:129-133.
60. Spitzer AL, Thoeni RF, Barcia AM, Schell MT and Harris HW.  Early non-enhanced abdominal CT can predict mortality in severe acute pancreatitis.  J Gastrointest Surg 2005;9:928-933.
61. Harris HW.  Lipoproteins are protective beyond HDL cholesterol and heart disease.  Crit Care Med. 2005 Aug;33(8):1859-60.
62. Harris HW, Davis BR and Vitale GC.  Cholecystectomy following endoscopic sphincterotomy for common bile duct stones: is surgery necessary?  Surg Innov 2005;12:187-194.
63. Spitzer AL, Mukhtar RA and Harris HW.  Image of the month. Arch Surg 2005;140:1005-006.
64. Schell MT, Spitzer AL, Johnson JA, Lee D and Harris HW.  Heat shock inhibits NF-kB activation in a dose- and time-dependent manner.  J Surg Res 2005;129:90-93.
65. Barcia AM and Harris HW.  Triglyceride-rich lipoproteins as agents of innate immunity.  Clin Infect Dis 2005;41 Suppl 7:S498-503.
66. Harris HW.  Apolipoprotein E: From Alzheimer’s to Sepsis.  Crit Care Med 2005;33:2696-2697.
67. Spitzer AL, Barcia AM, Schell MT, Barber A, Norman J, Grendell J and Harris HW.  Applying Ockham's razor to pancreatitis prognostication: A four-variable predictive model.  Ann Surg 2006;243:380-388.
68. Spitzer AL and Harris HW.  Statins attenuate sepsis.  Surgery 2006;139:283-287.
69. Paydar K, Hansen S, Harris HW and Young DM.  Inappropriate Antibiotic Use in Soft Tissue Infections.  Arch Surg. 2006;141:850-4.
70. Rajendran P, Young DM, Maurer T, Chambers H, Jacobson M, and Harris HW.  Antibiotic use in the treatment of soft tissue abscesses: a survey of current practice.  Surg Infect 2007;8:237-8.
71. Maa J, Gosnell JE, Gibbs VC and Harris HW.  Exporting excellence for whipple resection to refine the leapfrog initiative.  J Surg Res 2007;138:189-97.
72. Derish PA, Maa J, Ascher NL and Harris HW.  Enhancing the mission of academic surgery by promoting scientific writing skills.  J Surg Res 2007;140:177-83.
73. Maa J, Carter JT, Gosnell JE and Harris HW.  The surgical hospitalist: a new model for emergency surgical care?  J Am Coll Surg 2007;205:704–711.
74. Maa J, Gosnell JE, Carter JT, Wachter RM and Harris HW.  The surgical hospitalist: a new solution for emergency surgical care?  Bull Am Coll Surg 2007;92:8-17.
75. Rajendran PM, Young D, Maurer T, Chambers H, Perdreau-Remington F, Ro P and Harris H.  Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection.  Antimicrob Agents Chemother 2007;51:4044-8.
76. Kasravi B, Lee DH, Lee JW, Dada S and Harris HW.  Chylomicron-bound LPS selectively inhibits the hepatocellular response to proinflammatory cytokines.  J Surg Res 2008;146:96-103.
77. Maa J, Wachter RM, Gosnell JE and Harris HW.  The future of general surgery.  JAMA 2008;299:1015.
78. Jamshidi R, Harris H and Campbell AR.  The value of teaching anatomy to medical students (letter).  Bull Am Coll Surg 2008;93:36.
79. Schell MT, Barcia AM, Spitzer AL and Harris HW.  Pancreaticoduodenectomy: volume is not associated with outcome within an academic health care system.  HPB Surg. 2008;2008:825940.
80. Kattan OM, Kasravi FB, Elford EL, Schell MT, and Harris HW.  Apolipoprotein E mediated immune regulation in sepsis.  J Immunol 2008;181:1399-1408.
81. Mukhtar RA, Kattan OM and Harris HW.  Variation in annual volume at a university hospital does not predict mortality for pancreatic resections.  HPB Surg 2008 (PMID: 19259261).
82. Somsouk M, Shergill AK, Grenert JP, Harris H, Cello JP and Shah JN.  Actinomycosis mimicking a pancreatic head neoplasm diagnosed by EUS-guided FNA. Gastrointest Endo. 2008;68:186-7.
83. Jancelewicz T, Vu LT, Shawo AE, Yeh B, Gasper WJ and Harris HW.  Predicting strangulated small bowel obstruction: an old problem revisited.  J Gastrointest Surg. 2009;13:93-9.
84. Jamshidi R, Hill A, and Harris HW.  Anaphylaxis due to recurrent hydatid disease.  Surg Infect (Larchmt) 2009;10:155-7.
85. Mohebali K, Young DM, Hansen SL, Shawo A, Freise CE, Chang DS, Maa J, Harris HW.  Open incisional hernia repair at an academic tertiary care medical center.  Arch Surg 2009;144:848-52.
86. Schecter WP, Hirshberg A, Chang DS, Harris HW, Napolitano LM, Wexner SD, Dudrick SJ.  Enteric fistulas: principles of management.  J Am Coll Surg 2009;209:484-91.
87. Rogers SJ, Cello JP, Horn JK, Siperstein AE, Schecter WP, Campbell AR, Mackersie RC, Rodas A, Kreuwel HT, Harris HW.  Prospective randomized trial of LC+LCBDE vs ERCP/S+LC for common bile duct stone disease.  Arch Surg. 2010;145:28-33.
88. Chuang K, Elford EL, Tseng J, and Harris HW.  An expanding role for apolipoprotein E in sepsis and inflammation.  Am J Surg 2010;200:391-7.
89. Leung B and Harris HW.  NKT cells in sepsis.  Clin Dev Immunol 2010 (PMID: 20953368).
90. Chuang KI, Leung B, Hsu N, and Harris HW.  Heparin protects against septic mortality via apoE-antagonism.  Am J Surg 2011;202:325-335. (PMID: 21741028).
91. Leung B and Harris HW.  NKT cells: the culprits of sepsis?  J Surg Res 2011:167;87-95.
92. Spitzer AL, Chuang KI, Victorino GP, Kasravi B, Curran B, Lee D and Harris HW.  Chylomicrons combined with endotoxin moderate microvascular permeability.  Innate Immunity 2011:17;283-292.
93. Chuang K, Corley D, Postlethwaite D, Merchant M and Harris HW.  Does increased experience with laparoscopic cholecystectomy yield more complex bile duct injuries?  Am J Surg 2012;203:480-7. (PMID: 22326050).
94. Harris HW. Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis (commentary).  Br J Surg 2012;99:767.  (DOI: 10.1002/bjs.8747)
95. Primus FE and Harris HW.  A critical review of biologic mesh use in ventral hernia repairs under contaminated conditions.  Hernia 2013;17:21-30. (PMID:23296600).
96. Beard J, Oresanya L, Dicker R and Harris HW.  Characterizing the global burden of surgical disease: A Method to estimate inguinal hernia epidemiology in Ghana.  World J Surg 2013;37:498-503. (PMID: 23224074).
97. Primus FE, Harris HW.  A critical review of biologic mesh use in ventral hernia repairs under contaminated conditions.  Hernia 2013;17:21-30.  (PMID: 23296600).
98. Harris HW.  Biologic mesh for ventral hernia repair: a cautionary tale.  Ann Surg 2013;257:997-8 (PMID: 23629526)
99. Beard JH, Oresanya LB, Akoko L, Mwanga A, Dicker FA and Harris HW.  An estimation of inguinal hernia epidemiology adjusted for population age structure in Tanzania.  Hernia 2013 (PMID: 24241326)
100. Harris HW. Clinical outcomes of biologic mesh: where do we stand? Surg Clin North Am. 2013;93:1217-25. Epub 2013 Jul 13. (PMID:24035084).
101. Carter JT, Kaplan JA, Nguyen JN, Lin MY, Rogers SJ, Harris HW. A Prospective, Randomized Controlled Trial of Single-Incision Laparoscopic vs Conventional 3-Port Laparoscopic Appendectomy for Treatment of Acute Appendicitis. J Am Coll Surg. 2014;218:950-9. (PMID: 24684867).
102. Sanchez Rodriguez R, Pauli ML, Neuhaus IM, Yu SS, Arron ST, Harris HW, Yang SH, Anthony BA, Sverdrup FM, Krow-Lucal E, Mackenzie TC, Johnson DS, Meyer EH, Löhr A, Hsu A, Koo J, Liao W, Gupta R, Debbaneh MG, Butler D, Huynh M, Levin EC, Leon A, Hoffman WY, McGrath MH, Alvarado MD, Ludwig CH, Truong HA, Maurano MM, Gratz IK, Abbas AK, Rosenblum MD. Memory regulatory T cells reside in human skin. J Clin Invest. 2014;124:1027-36. (PMID: 24509084).
103. Brown I, Bellevue O, Shawo A, Woldesemayat H, Lyo V, Rayikanti B, Lee M, Uzosike ED, Kasravi S and Harris HW.  Low dose cyclophosphamide improves survival in a murine treatment model of sepsis.  Shock. 2015;43:92-8. (PMID: 25243421).
104. Wong A, Lee S, Nathan NS, Wang F, Hansen SL, Harris HW and Sbitany H.  Postoperative prophylactic antibiotic use following ventral hernia repair with placement of surgical drains reduces postoperative surgical site infection. Plast Reconstr Surg 2015;136(4 Suppl):12-3.  (PMID: 26397498).
105. Bettini A, Ulloa J, Harris H.  Appendicitis with Morgagni Hernia and simultaneous paraesophageal hernia.  BMC Surg 2015;15:15.  (PMID: 25644716).
106. Liao A, Harris HW and Maharbiz MM.  Towards a full-field strain sensor for guiding hernia repairs.  Conf Proc IEEE Eng Med Biol Soc. 2015 Aug;2015:1243-6. (PMID: 26736492).
107. Kim SS, Nakakura EK, Wang ZJ, Kim GE, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Ko AH.  Preoperative FOLFIRINOX for borderline resectable pancreatic cancer: Is radiation necessary in the modern era of chemotherapy?  J Surg Oncol 2016;114:587-596. (PMID: 27444658).
108. Urisman T, Garcia A, Harris HW.  Impact of surgical intensive care unit interdisciplinary rounds on interprofessional collaboration and quality of care: mixed qualitative-quantitative study.  Intensive Crit Care Nurs 2018;44:18-23. (PMID: 28865984).
109. Liao A, Harris HW and Maharbiz MM.  Integrating coupled magnetoelastic sensors onto a flexible hernia mesh for high dynamic range strain measurements.  Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:1736-1739. (PMID: 29060222).
110. Lebares CC, Guvva EV, Ascher NL, O’Sullivan PS, Harris HW and Epel ES.  Burnout and stress amoung US surgery residents: psychological distress and resilience.  J Am Coll Surg 2018;226:80-90. doi: 10.1016/j.jamcollsurg.2017.10.010. (PMID: 29107117).
111. Primus FE, Young DM, Grenert JP and Harris HW. Silver microparticles plus fibrin tissue sealant prevents incisional hernias in rats. J Surg Res 2018;227:130-136. (PMID: 29804844).
112. Harris HW, Hope WH, Adrales G, Andersen DK, Deerenberg EB, Diener H, Dumanian G, East B, Fischer JP, Ureña MAG, Gibeily GJ, Hansson BM, Hernández-Granados P, Hiles MC, Jeekel J, Levinson H, Lopez-Cano M, Muysoms F, Pereira JA, Prudhomme M, Ramaswamy A, Stabilini C, Torkington J, Valverde S, Young DM. Contemporary concepts in hernia prevention: selected proceedings from the 2017 Symposium on Prevention of Incisional Hernias. Surgery 2018;164:319-326. (PMID: 29705098)
113. Okoroh JS, Essoun S, Seddoh A, Harris H, Weissman JS, Dsane-Selby L, Riviello R. Evaluating the impact of the national health insurance scheme of Ghana on out of pocket expenditures - A systematic review. BMC Health Services Research 2018;18:426 (PMID: 29879978).
114. Ross JT, Matthay MA, Harris HW. Secondary peritonitis: principles of diagnosis and intervention. BMJ. 2018;361:k1407. (PMID: 29914871).
115. Lebares CC, Hershberger AO, Guvva EV, Desai A, Mitchell J, Shen W, Reilly LM, Delucchi KL, O'Sullivan PS, Ascher NL, Harris HW. Feasibility of formal mindfulness-based stress-resilience training among surgery interns: a randomized clinical trial. JAMA Surg. 2018;153:e182734 (PMID: 30167655).
116. Kim SS, Ko AH, Nakakura EK, Wang ZJ, Corvera CU, Harris HW, Kirkwood KS, Hirose R, Tempero MA, Kim GE. Comparison of tumor regression grading of residual pancreatic ductal adenocarcinoma following neoadjuvant chemotherapy without radiation: would fewer tier-stratification be favorable toward standardization? Am J Surg Pathol. 2018 Sep 11 (PMID: 30211728).
117. Liao A, Harris HW, Maharbiz MM. A coupled magnetoelastic strain sensor array for guiding and monitoring hernia repairs. IEEE Trans Biomed Eng. 2019;66:4-13 (PMID: 29993427).
118. Fischer JP, Harris HW, López-Cano M, Hope WW. Hernia prevention: practice patterns and surgeons’ attitudes about abdominal wall closure and the use of prophylactic mesh. Hernia 2019;23:329-334 (PMID: 30734888).
119. Green CA, Mahuron KM, Harris HW, O’Sullivan PS. Integrating robotic technology into resident training: challenges and recommendations from the front lines. Acad Med. 2019;94:1532-1538. (PMID: 30998574).
120. Lebares CC, Guvva EV, Olaru M, Sugrue LP, Staffaroni AM, Delucchi KL, Kramer JH, Ascher NL, Harris HW. Efficacy of mindfulness-based cognitive training in surgery; an additional analysis of the mindful surgeon pilot randomized clinical trial. JAMA Network Open. 2019;2:e194108. Doi:10.1001/jamanetworkopen.2019.4108. (PMID: 31125095)
121. Beard JH, Ohene-Yeboah M, Tabiri S, Amoako JKA, Abantanga FA, Sims CA, Nordin P, Wladis A, Harris HW, Lofgren J. Outcomes after inguinal hernia repair with mesh performed by medical doctors and surgeons on Ghana. JAMA Surg. 2019 Jun 26. doi: 10.1001/jamasurg.2019.1744. (PMID: 31241736)
122. Lopez-Cano M. Harris HW, Fisher JP, Pereira JA, Garcia-Alamino JM, Hope WW. Practice patterns and attitudes of surgeons on the use of prophylactic mesh to prevent parastomal hernia: a cross-sectional survey. Wound Manag Prev. 2019;65:14-23. (PMID: 31702989)
123. Lowe MM, Boothby I, Clancy S, Ahn RS, Liao W, Nguyen DN, Schumann K, Marson A, Mahuron KM, Kingsbury GA, Liu Z, Munoz Sandoval P, Rodriguez RS, Pauli ML, Taravati K, Arron ST, Neuhaus IM, Harris HW, Kim EA, Shin US, Krummel MF, Daud A, Scharschmidt TC, Rosenblum MD. Regulatory T cells use arginase 2 to enhance their metabolic fitness in tissues. JCI Insight. 2019 Dec 19;4(24). pii: 129756. doi: 10.1172/jci.insight.129756. (PMID: 31852848)
124. Lebares CC, Guvva EV, Desai A, Herschberger A, Ascher NL, Harris HW, O’Sullivan P. Key factors for implementing mindfulness-based burnout interventions in surgery. Am J Surg. 2020;219:328-334. (PMID: 31668282)
125. Okoroh J, Sarpong DO, Essoun S, Riviello R, Harris H, Weissman JS. Does insurance protect individuals from catastrophic payments for surgical care? An analysis of Ghana’s National Health Insurance Scheme at Korle-Bu teaching hospital. BMC Health Serv Res. 2020 Jan 17;20(1):45. doi: 10.1186/s12913-020-4887-2. (PMID: 31952520)
126. Young CS, Lyo V, Harris HW. Fascial defect size predicts recurrence following incisional hernia repair: a 7-year, single surgeon experience. Int J Abdom Wall Hernia Surg 2020;3:11-17.
127. Conroy PC, Colley A, Bongiovanni T, Chang TT, Harris H. Jejunal prolapse and incarceration following feeding tube exchange. J Trauma Acute Care Surg. 2020 12; 89(6):e175-e176. PMID: 32925576
128. Lowe MM, Naik HB, Clancy S, Pauli M, Smith KM, Bi Y, Dunstan R, Gudjonsson J, Paul M, Harris H, Kim EA, Shin US, Ahn R, Liao W, Hansen SL, Rosenblum M. Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF therapy. JCI Insight. 2020 Aug 25:139932. doi: 10.1172/jci.insight.139932. (PMID: 32841223)
129. Lebares CC, Coaston TN, Delucchi KL, Guvva EV, Shen WT, Staffaroni AM, Kramer JH, Epel ES, Hecht FM, Ascher NL, Harris HW, Cole SW. Enhanced stress resilience training in surgeons: iterative adaptation and biopsychosocial effects in 2 small randomized trials. Ann Surg. 2021;273:424-432. (PMID: 32773637)
130. Ross JT, Liang NE, Lebares CC, Carter J, Harris HW, Cello JP, Rogers SJ, Lin MY. Upper gastrointestinal endoscopy in an academic general surgical program: implications for acute care surgeons. Surg Innovation. doi:10.1177/1553350620957802.
131. Harris HW, Primus F, Young C, Carter JT, Lin M, Mukhtar RA, Yeh B, Allen IE, Freise C, Kim E, Sbitany H, Young DM, Hansen S. Preventing recurrence in clean and contaminated hernias using biologic versus synthetic mesh in ventral hernia repair: the PRICE randomized clinical trial. Ann Surg. 2021;273:648-655 (PMID: 33443907).
132. Thiruvengadam NR, Miranda J, Kim C, Behr S, Corvera C, Dai SC, Kirkwood K, Harris HW, Hirose K, Nakakura E, Ostroff JW, Kochman ML, Arain MA. Burden of ionizing radiation in the diagnosis and management of necrotizing pancreatitis. Clin Transl Gastroenterol. 2021 Apr 27;12(5):e00347. doi: 10.14309/ctg.0000000000000347 (PMID: 33904509).
133. Mehta P, Gouirand V, Boda DP, Zhang J, Gearty SV, Zirak B, Lowe MM, Clancy S, Boothby I, Mahuron KM, Fries A, Krummel MF, Mankoo P, Chang HW, Liu J, Moreau JM, Scharschmidt TC, Daud A, Kim E, Neuhaus IM, Harris HW, Liao W, Rosenblum MD. Layilin anchors regulatory T cells in skin. J Immunol. 2021;207:1763-1775 (PMID:34470859)
134. Boothby IC, Kinet MJ, Boda DP, Kwan EY, Clancy S, Cohen JN, Habrylo I, Lowe MM, Pauli M, Yates AE, Chan JD, Harris HW, Neuhaus IM, McCalmont TH, Molofsky AB, Rosenblum MD. Early-life inflammation primes a T helper2 cell-fibroblast niche in skin. Nature. 2021 Nov;599(7886):667-672. doi: 10.1038/s41586-021-04044-7. Epub 2021 Oct 27. (PMID: 34707292)
135. Deerenberg EB, Henriksen NA, Antoniou GA, Antoniou SA, Bramer WM, Fischer JP, Fortelny RH, Gok H, Harris HW, Hope W, Horne CM, Jensen TK, Kockerling F, Kretschmer A, Lopez-Cano M, Malcher F, Shao JM, Slieker JC, deSmet GHJ, Stabilini C, Torkington J, Muysoms FE. Updated guideline for closure of abdominal wall incisions from the European and American Hernia Societies. Br J Surg. 2022;109:1239-1250. (PMID: 36026550)
136. Beard JH, Thet Lwin ZM, Agarwal S, Ohene-Yeboah M, Tabiri S, Amoako JKA, Maher Z, Sims CA, Harris HW, Löfgren J. Cost-effectiveness analysis of inguinal hernia repair with mesh performed by surgeons and medical doctors in Ghana. Value Health Reg Issues. 2022;32:31-38. (PMID: 36049447)
137. Harris HW. Innovations for incisional hernia prevention. J Abdom Wall Surg. 2022;1:10945 (doi:10.3389/jaws.2022.10945).
138. Lima DL, Mohamedaly S, Hollins A, Yoo J, Harris H, Malcher F. A novel polypropylene mesh (T-Line) for abdominal wall repair: early experience at three centers in the United States. Surg Technol Int. 2023;42:163-167. doi: 10.52198/23.STI.42.HR1649. (PMID: 36724298)
139. Dhanani NH, Lyons NB, Divino CM, Harris H, Holihan JL, Hope W, Itani K, Loor MM, Martindale R, Prabhu A, Reinke C, Roth JS, Towfigh S, Liang MK. Expert consensus for key features of operative reports of ventral hernia. J Am Coll Surg. 2023;236:235-240. (PMID: 36102528)
140. Starr N, Tadesse M, Igwebuike C, Sherefa K, Genetu A, Aregawi Y, Zewdu E, Tamirat D, Desalegn M, Getahun B, Harris H, Zemenfes D. Feasibility of gastrografin use for adhesive small bowel obstruction in low-income countries. J Surg Res. 2023;293:239-247.
141. DeLong MR, Wells MW, Chang IA, Vardanian AJ, Harris H. Data requirement for animal-derived wound care devices: limitations of the 510(k) regulatory pathway. J Am Coll Surg. 2024;238:218-224. doi: 10.1097/XCS.0000000000000884. (PMID: 37796150)
142. Lowe MM, Cohen JN, Moss MI, Clancy S, Adler JP, Yates AE, Naik HB, Yadav R, Pauli M, Taylor I, McKay A, Harris H, Kim E, Hansen SL, Rosenblum MD, Moreau JM. Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa. JCI Insight 2024;9:e169870. doi: 10.1172/jci.insight.169870. (PMID: 38113104)
143. Diab MM, Patel S, Young C, Allen IE, Harris HW. Quality of life measure and cost analysis of biologic versus synthetic mesh for ventral hernia repair: The Preventing Recurrence in Clean and Contaminated Hernias randomized clinical trial. Surgery 2024;175:1063-1070. doi: 10.1016/j.surg.2023.11.013. (PMID: 38135553)
144. Leboit PE, Patel DU, Cohen JN, Moss MI, Naik HB, Yates AE, Harris HW, Klufas DM, Kim EA, Neuhaus IM, Hansen SL, Kyle RL, Kelly M, Rosenblum MD, Lowe MM. A novel whole tissue explant model of hidradenitis suppurativa. bioRxiv [Preprint]. 2024 Jul 23:2024.07.19.603617. doi: 10.1101/2024.07.19.603617. (PMID: 39211108)

CHAPTERS

1. Harris HW and Pellegrini CA.  Alkaline Reflux Gastritis.  IN:  Current Therapy in Gastroenterology and Liver Disease, Bayless TM (ed.), B.C. Decker, Inc., Toronto, Canada, pp. 99-101. 1990.
2. Harris HW and Pellegrini CA.  Cholecystectomy-Cholecystostomy.  IN:  Surgical Disease of the Biliary
3. Tract and Pancreas, Braasch JW and Tompkins RK (eds.), Mosby Year Book, Chicago, IL, 1994.
4. Harris HW.  Fasting and Postprandial Lipoproteins Abrogate the Effects of Endotoxin in Humans.  IN:  Proceedings from the Fourth International Congress on The Immune Consequences of Trauma, Shock and Sepsis, Faist E (ed.), Bologna:  Monuzzi Editore, 1997:41-44.
5. Harris HW and Schecter WP.  Emergency Abdominal Surgery.  IN: The role of surgery in AIDS, Flum DR and Wallack MK (eds.), Lippincott Williams & Wilkins, Baltimore, MD, 1999.
6. Harris HW and Schecter WP.  HIV and the Management of Soft Tissue Infections.  IN: AIDS and HIV-Infections, Jäeger H (ed.), Ecomed Verlag, Landsberg, Germany, 2000.
7. Harris HW.  Biliary System.  IN: Surgery: scientific basis and current practice, Norton et al (eds.), Springer-Verlag, New York, NY. 2001:553-584.
8. Gosnell JE, Jan J, Harris HW and Schecter WP. Human Immunodeficiency Virus Infection.  IN: The practice of general surgery, Bland KI (ed.), WB Saunders, Philadelphia, PA.2001:38-47.
9. Schell MT and Harris HW.  Inflammatory Bowel Disease, Surgical Considerations, The Biliary Tree, The Pancreas and Bariatric Surgery.  IN: Gastroenterology: Quick Glance, Edwards, Z. Colette (ed.), McGraw-Hill Companies, New York, NY, 2005: 53-62, 129-134, 145-168, and 235-240.
10. Chuang K and Harris HW.  The lipemia of sepsis:  triglyceride-rich proteins as agents of innate immunity. Sepsis: Symptoms, Diagnosis, and Treatment. Novascience publishers 2010; Chapter 4:75-92.
11. Harris HW.  Management of enterocutaneous fistulas.  IN: Current Surgical Therapy, Cameron JL and Cameron AM (eds.), Elsevier Saunders, Philadelphia, PA, 2011:127-130.
12. Kouanda AM, Munroe CA, Harris HW. Management of Complications of Acute and Chronic Pancreatitis: Endoscopic, Laparoscopic, and Open Approaches to Pancreatic Pseudocysts and Pancreatic Necrosis . IN: Fischer’s Mastery of Surgery, 8th Edition, Ellison EC and Upchurch GR (eds.), Wolters Kluwer, Alphen aan den Rijn, the Netherlands, 2023.

ABSTRACT PRESENTATIONS (selected)

1. Harris HW, Rapp JH, Kunitake ST, Krupski WC and Kane JP.  Modified low density lipoprotein isolated from fresh human atherosclerotic plaque.  Read before the Forum on Fundamental Surgical Problems, American College of Surgeons, Chicago, Illinois, October 23-28, 1988.
2. Harris HW, Rapp JH, Reilly LM, Orlando PA, Krupski WC and Goldstone J.  Saphenous vein bypass to pedal arteries.  Read before the 60th Annual Meeting of the Pacific Coast Surgical Association, Vancouver, Canada, February 22, 1989.
3. Harris HW and Rapp JH.  Chylomicrons neutralize endotoxin activity.  Read before the 32nd Annual University Surgical Resident’s Conference, Society of University Surgeons, Los Angeles, California, February 10, 1990.
4. Harris HW, Grunfeld C, Feingold KR and Rapp JH.  Human VLDL and chylomicrons can protect against endotoxin-induced death in mice.  Poster presentation at the 1990 AAP/ASCI/AFCR National Meeting, Washington, D.C., May 4-7, 1990.
5. Grunfeld C, Harris HW, Feingold KR and Rapp JH.  A teleological explanation for tumor necrosis factor induced hypertriglyceridemia:  VLDL and other triglyceride-rich particles protect from the toxic effects of endotoxin.  Read before the 3rd International Conference on Tumor Necrosis Factor and Related Cytokines, Makuhari, Chiba, Japan, November 21-25, 1990.
6. Harris HW, Grunfeld C, Feingold KR and Rapp JH.  Mechanism of protection against endotoxemia by chylomicrons in rats.  Read before the Society of Black Academic Surgeons, Boston, Massachusetts, April 7-9, 1991.
7. Jarnagin WR, Mulloy R, Harris HW, Bossart J, Heer W and Hickey M.  Malnutrition in AIDS-related PCP pneumothorax.  J Am Coll Nutrition 1993;12:596.
8. Sperling RM, Koch J, Harris HW, Sandhu FS and Cello JP.  Natural history of recurrent pyogenic cholangitis in Asian immigrants to the U.S.  Poster presentation before the Annual Meeting of the American Society for Gastrointestinal Endoscopy, San Diego, California, May 14-17, 1995.
9. Sperling RM, Koch J, Harris HW, Sandhu  and Cello JP.  Role of therapeutic ERCP in the management of recurrent pyogenic cholangitis (RPC).  Poster presentation before the Annual Meeting of the American Society for Gastrointestinal Endoscopy, San Diego, California, May 14-17, 1995.
10. Hojman H, Harris HW and Horn J.  Induction of apoptosis by injection of LPS into human volunteers.  Presentation before the Annual Meeting of the Surgical Infection Society, 1996.
11. Ghermay AP, Brady S, Harris HW, Havel R and Rapp JH.  Sepsis increases endocytosis of endotoxin by
12. hepatocytes.  Presentation before the Annual Meeting of the Society of University Surgeons, Washington, D.C., February 8-10, 1996.
13. Harris HW, Rockey DC, Chau PL, Kane JP and Rapp JH.  Effect of chylomicrons on the clearance of endotoxin by hepatocytes.  Presentation before the Forum on Fundamental Surgical Problems, American College of Surgeons, San Francisco, California, October 6-11, 1996.
14. Harris HW.  Fasting and postprandial lipoproteins abrogate the effects of endotoxin in humans.  Presented at the Fourth International Congress on the Immune Consequences of Trauma, Shock and Sepsis, Munich, Germany, March 4-8, 1997.
15. Harris HW and Chau PL.  Endogenous hypertriglyceridemia protects against endotoxin.  Presented at the Seventh Annual Scientific Assembly, Society of Black Academic Surgeons, Buffalo, New York, April 9-12, 1997.
16. Harris HW, Chau PL, Rapp JH, Kane JP and Rockey DC.  Chylomicrons alter the clearance and response to endotoxin by hepatocytes.  Presented at the Annual Meeting during Digestive Disease Week, Washington, D.C., May 11-14, 1997.
17. Kumwenda ZL, Welch WJ, and Harris HW.  Chylomicron-bound endotoxin inhibits hepatocellular nitric oxide production by inhibiting nuclear factor B activation in rats.  Presented at the Forum on Fundamental Surgical Problems, American College of Surgeons, Orlando, Florida, October 24-29, 1998.
18. Kumwenda ZL, Welch WJ, and Harris HW.  Chylomicrons can regulate hepatic gene expression.  Presented at annual meeting of the Society of Black Academic Surgeons, Louisville, Kentucky, March 18-20, 1999.
19. Gosnell JE, Welch WJ, and Harris HW.  The extracellular matrix can regulate the hepatocellular response to cytokines.  Presented at annual meeting of the Society of Black Academic Surgeons, Louisville, Kentucky, March 18-20, 1999.
20. Gosnell JE, Welch WJ, and Harris HW.  The extracellular matrix regulates the hepatocellular response to stress.  Presented at annual meeting of the National Medical Association, Las Vegas, Nevada, August 8-11, 1999.
21. Kumwenda ZL, Welch WJ, and Harris HW.  Chylomicron-bound endotoxin selectively inhibits nuclear transcription factor-B in rat hepatocytes.  Presented at the Forum on Fundamental Surgical Problems, American College of Surgeons, San Francisco, California, October 10-15, 1999.
22. Gosnell JE, Welch WJ, and Harris HW.  The extracellular matrix regulates the hepatocellular stress response.  Presented at the Forum on Fundamental Surgical Problems, American College of Surgeons, San Francisco, California, October 10-15, 1999.
23. Gosnell JE and Harris HW.  Necrotizing pancreatitis: an aggressive surgical approach via marsupialization of the retroperitoneum.  Pan-Pacific Surgical Association, Honolulu, HI, January 29-February 3, 2000.
24. Gosnell JE, Welch WJ, and Harris HW.  Heat shock inhibits the acute phase response in primary rat hepatocytes.  Presented at the annual meeting of the Society of Black Academic Surgeons, Los Angeles, CA, April 27-29, 2000.
25. Liu Q, Fischer H, Welch WJ and Harris HW.  Cerulein-induced acute pancreatitis is more severe in mice heterozygous for the F508 cystic fibrosis transmembrane conductance regulator gene mutation than wild-type controls.  Presented at the annual meeting of the Association for Academic Surgery, Tampa, FL, November 2-4, 2000.
26. Harris HW, Johnson JA, Lee DH, and Welch WJ.  Heat shock regulates NF-kB activation.  Presented at the annual meeting of the Association for Academic Surgery, Milwaukee, WI, November 15-17, 2001.
27. Harris HW, Brady SE, and Rapp JH.  Hepatic endosomal trafficking of lipoprotein-bound endotoxin in rats.  Presented at the annual meeting of the Association for Academic Surgery, Milwaukee, WI, November 15-17, 2001.
28. Wasilewski M, Disch D, McGill J, Harris HW, O’Riordan W, and Zeckel M.  Equivalence of shorter course therapy with oritavancin compared to vancomycin/cephalexin in complicated skin/skin structure infections.  Presented at the 41st ICAAC, Chicago, IL, December 2001.
29. Harris HW and Kasravi FB.  Apolipoprotein E isoforms predict the hepatic response to endotoxin.  Poster presentation at the Twenty-fifth Annual Conference on Shock, Big Sky, Montana, June 8-11, 2002.
30. Kasravi FB and Harris HW.  Lipoproteins protect against endotoxemia by inducing hepatic tolerance to cytokines.  Poster presentation at the Twenty-fifth Annual Conference on Shock, Big Sky, Montana, June 8-11, 2002.
31. Kasravi FB and Harris HW.  Apolipoprotein E isoforms predict the hepatic response to sepsis.  Presented at the Forum on Fundamental Surgical Problems, American College of Surgeons, San Francisco, California, October 6-10, 2002.
32. Kasravi FB, Lee D and Harris HW.  Chylomicron-bound LPS selectively inhibits the hepatocellular response to proinflammatory cytokines.  Presented at the 23rd Annual Meeting of the Surgical Infection Society, San Antonio, Texas, April 10-12, 2003.
33. Kasravi FB and Harris HW.  Lipoprotein-bound endotoxin exerts an immunomodulatory effect on hepatocytes through the lipid A domain of LPS.  Presented at the 23rd Annual Meeting of the Surgical Infection Society, San Antonio, Texas, April 10-12, 2003.
34. Spitzer AL, Victorino GP, Kasravi F, Curran B, Chang J and Harris HW.  Chylomicron-bound LPS inhibits tumor necrosis factor-induced capillary leak in vivo.  Presented at the 38th Annual Meeting of the Association for Academic Surgery, Houston, Texas, November 11-13, 2004.
35. Carpino CE, Schell MT, Kasravi KF, Spitzer AL and Harris HW.  Cecal ligation and perforation is associated with adrenal insufficiency in rats.  Presented at the 38th Annual Meeting of the Association for Academic Surgery, Houston, Texas, November 11-13, 2004.
36. Mukhtar RA, Kasravi FB and Harris HW.  Chylomicron-lipotechoic acid complexes induce cytokine tolerance in primary rat hepatocytes.  Presented at the 25th Annual Meeting of the Surgical Infection Society, Miami, Florida, May 5-7, 2005.
37. Spitzer AL, Victorino G, Lee D, Kasravi B, Curran B, and Harris H.  Lipoprotein-bound endotoxin moderates microvascular permeability.  Presented at the 56th Annual Sessions of the Surgical Forum 2005 Clinical Congress, San Francisco, CA, October 16-20, 2005.
38. Maa J, Gosnell JE, Harris HW and Gibbs VC.  Revising the leapfrog initiative: exporting surgical excellence for whipple resection.  Presented at the 1st Annual Academic Surgical Congress, San Diego, CA, February 7-11, 2006.
39. Paydar KZ, Harris HW, Hansen SL, Charlebois ED and Young DM.  Inappropriate antibiotic use in uncomplicated soft tissue infections.  Presented at the 77th Annual Meeting of the Pacific Coast Surgical Association, San Francisco, CA, February 17-20, 2006.
40. Mohebali K, Hansen SL, Maa J, Young DM, Freise CE, Chang D and Harris HW.  Recurrence rate and complications of open incisional hernia repair at an academic tertiary care medical center.  Presented at the 80th Annual Meeting of the Pacific Coast Surgical Association, San Francisco, CA, February 13-16, 2009.
41. Chuang K, Kattan O, Leung B, Presser N, and Harris HW.  Apolipoprotein E regulates septic mortality in mice.  Society of Black Academic Surgeons.  April 4, 2009.  Seattle, WA. 
42. Chuang K, Elford E, and Harris HW.  Endogenous ligands contribute to natural killer T cell activation.  Society of Black Academic Surgeons.  April 4, 2009.  Seattle, WA.
43. Chuang K, Elford E, and Harris HW.  Endogenous ligands contribute to natural killer T cell activation.  Shock Society.  June 9, 2009.  San Antonio, TX.
44. Chuang K, Hsu N, Leung B, Bien-Ly N, Raffai R, and Harris HW.  Heparin protects against septic mortality via apoE antagonism.  AAS-SUS (Academic Surgical Congress).  February 3, 2010.  San Antonio, TX. 
45. Chuang K, Corley D, Postlethwaite D, Merchant M, and Harris HW.  Does increased experience with laparoscopic cholecystectomy yield more complex bile duct injuries?  Pacific Coast Surgical Association.  February 14, 2010.  Kapalua, Maui. 
46. Chuang K, Hsu N, Leung B, Bien-Ly N, Raffai R, and Harris HW.  Heparin protects against septic mortality via apoE antagonism.  UCSF Resident Research Symposium.  March 12, 2010.  San Francisco, CA. 
47. Chuang K, Corley D, Postlethwaite D, Merchant M, and Harris HW.  Does increased experience with laparoscopic cholecystectomy yield more complex bile duct injuries?  Alameda County Medical Center Surgery/Emergency Medicine Resident Research Day.  March 24, 2010.  Oakland, CA. 
48. Chuang K, Leung B, Hsu N, and Harris HW.  Heparin protects against septic mortality via apoE antagonism.  American College of Surgeons.  October 5, 2010.  Washington, D.C.
49. Brown IE, Shawo A, Bellevue O, Rayikanti B, Abram C and Harris HW.  Low dose cyclophosphamide improves survival in a treatment model of sepsis.  Shock Society. June 9-13, 2012.  Miami Beach, FL.
50. Seiser N, Kasravi S, Leung B, Primus F and Harris HW.  Apolipoprotein E deficiency protects against septic mortality.  Shock Society. June 9-13, 2012.  Miami Beach, FL.
51. Brown IE, Shawo A, Bellevue O, Rayikanti B and Harris HW. Low dose cyclophosphamide augments survival in a murine treatment model of severe sepsis.  American College of Surgeons.  September 30 – October 3, 2012.  Chicago, IL.
52. Primus F, Shin US, Thoeni R and Harris H.  Short- and long-term results of blunt necrosectomy for necrotizing pancreatitis.  Pacific Coast Surgical Association.  February 16-19, 2013.  Kauai, HI.
53. Woldesemayat H, Yano J and Harris H.  ApoE regulates pathogen clearance in mice.  Society of Black Academic Surgeons.  April 25-27, 2013.  Jackson, MS.
54. Kasravi S and Harris HW.  ApoE mediates septic mortality in mice by a natural killer (NKT) T cell-dependent mechanism.  Society of Black Academic Surgeons.  April 25-27, 2013.  Jackson, MS.
55. Carter J, Kaplan J, Nguyen J, Lin M, Rogers S and Harris H.  A prospective, randomized, controlled trial of single-incision laparoscopic (SILS) versus conventional 3-port laparoscopic appendectomy for the treatment of acute appendicitis. American College of Surgeons, October 6-10, 2013, Washington, D.C.
56. Irwin CS, Xu X, Hoffman WY and Harris H.  Preoperative progressive pneumoperitoneum for the treatment of gigantic ventral hernias.  American Association of Plastic Surgeons, April 5-8, 2014, Miami, FL.
57. Lee MH and Harris HW.  ApoE mediates septic mortality in mice by regulating macrophage phenotype and activity. Shock Society, June 7-10, 2014, Charlotte, North Carolina.
58. Kasravi S and Harris HW.  ApoE and NKT cells mediate serum creatinine levels in mice during sepsis. Shock Society, June 7-10, 2014, Charlotte, North Carolina.
59. Lyo V, Tufaga M, Shin UK, Primus F and Harris H.  Wound class does not alter recurrence in complex ventral hernia repair with mesh: a single-center retrospective review.  1st World Conference on Abdominal Wall Hernia Surgery, April 25-29, 2015, Milan, Italy.
60. Lyo V, Irwin C, Xu X and Harris H.  Safe and effective management of massive ventral hernias with preoperative progressive pneumoperitoneum: a tertiary care hospital experience.  1st World Conference on Abdominal Wall Hernia Surgery, April 25-29, 2015, Milan, Italy.
61. Liao A, Harris HW and Maharbiz MM.  Towards a full-field strain sensor for guiding hernia repairs.  37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, August 25-29, 2015, Milan, Italy.
62. Wong A, Lee S, Nathan NS, Wang F, Hansen SL, Harris HW and Sbitany H.  Postoperative prophylactic antibiotic use following ventral hernia repair with placement of surgical drains reduces postoperative surgical site infection rate.
63. Lyo V, Tufaga M, Shin U, Primus F, Fong S and Harris HW.  Wound class does not alter recurrence in complex ventral hernia repair with mesh: a single-center retrospective review.  Pacific Coast Surgical Association.  February 13-16, 2016, Kohala Coast, HI.
64. Kumar S, Kaplan J, Lin M, Harris H and Carter J.  Obesity is a stronger predictor of soft tissue infection after abdominal wall reconstruction than hernia-specific technical factors.  Americas Hernia Society. March 30 – April 2, 2016, Washington, DC.
65. Kaplan J, Lin M, Yoo J, Rogers S, Harris H and Carter J.  Should elective hernia repair be performed in the severely obese? Clinical outcomes of modern techniques of abdominal wall reconstruction.  Americas Hernia Society. March 30 – April 2, 2016, Washington, DC.
66. Kaplan J, Lin M, Yoo J, Rogers S, Harris H and Carter J.  A predictor model for serious complications early after ventral hernia repair incorporating detailed patient, hernia and technique-related factors.  Americas Hernia Society, March 30 – April 2, 2016, Washington, DC.
67. Beard JH, Ohene-Yeboah M, Wladis A, Sims CA, Nordin P, Harris HW, Lofgren J.  Outcomes after low cost mesh repair of inguinal hernias performed by surgeons and non-surgeons in Ghana.  Americas Hernia Society, March 8-11, 2017, Cancun, Mexico.
68. Liao A, Harris HW and Maharbiz MM. Integrating coupled magnetoelastic sensors onto a flexible hernia mesh for high dynamic range strain measurements.  39th Annual International Conference of the IEEE Engineering in Medicine and Biology Society, July 11-15, 2017, Jeju Island, Korea.
69. Primus F and Harris HW. Silver microparticles prevent incisional hernias in rats.  Forum on Fundamental Surgical Problems, American College of Surgeons, October 22-26, 2017, San Diego, CA.
70. Young, C, Lyo V, Primus F, Tufaga M, Shin US, Fong S and Harris HW. Fascial defect size predicts recurrence following incisional hernia repair. International Hernia Congress, March 12-15, 2018, Miami, FL.
71. Harris HW, Primus F, Tufaga M, Young C, Shin US, Carter JT, Lin M, Mukhtar RA, Black D, Yeh B, Sbitany H, Freise C, Kim E, Young DM, Fong SL and Hansen S. Preventing recurrence in clean and contaminated hernias (PRICE): a randomized trial of biologic versus synthetic mesh in ventral hernia repair. 41st Annual International Congress of the European Hernia Society, September 11-14, 2019, Hamburg, Germany.
72. Harris HW, Primus F, Tufaga M, Young C, Shin US, Carter JT, Lin M, Mukhtar RA, Black D, Yeh B, Sbitany H, Freise C, Kim E, Young DM, Fong SL and Hansen S. Preventing recurrence in clean and contaminated hernias (PRICE): a randomized trial of biologic versus synthetic mesh in ventral hernia repair. Surgery Grand Rounds, Renown Regional Medical Center, October 10, 2019, Reno, NV.
73. Primus F, Young C, Young DM and Harris HW. Silver microparticles plus fibrin accelerates diabetic wound healing.  Forum on Fundamental Surgical Problems, American College of Surgeons, October 27-31, 2019, San Francisco, CA.

MOTION PICTURES/VIDEOS

1.    Harris HW, Way LW, Patti MG, Gantert WA, Yamagata S, and Arcerito M.  Laparoscopic Repair of a paraesophageal hernia.  Shown as part of the Symposium on Unusual Problems in Surgery, Motion Picture Exhibitions.  American College of Surgeons, Chicago, Illinois, October 12-17, 1997.
2.    Harris HW and Corvera C.  VIPoma.  Shown as part of the UCSF Postgraduate Course in General Surgery, Video Session, San Francisco, CA, March 27-29, 2008.

GRANT SUPPORT

Active

DLV-HE-018              Harris (Investigator)              06/01/20 – 05/31/27

Davol, Inc.

Prophylactic Reinforcement of Ventral Abdominal Incisions Trial (PREVENT): Prospective, Multi-Center, Open-Label, Randomized, Controlled Trial of Phasix Mesh to Prevent Incisional Hernia Subsequent to Open Midline Laparotomy.

Pending

M24-846              Harris (Investigator)             

AbbVie, Inc.

A Phase 2b Double-Blind, Placebo-Controlled, Adaptive, Dose-Escalation Study to Evaluate the Safety and Efficacy of AGN-151607-DP for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique, in Subjects Undergoing Open Abdominal Ventral Hernia Repair.

BIOENTREPRENEURSHIP

2009              Inventor, MYOSEAL – a product design to prevent incisional hernias through enhanced wound healing.

2012 - present              Founder & President, Vitruvian Medical Devices, Inc.

2015 - 2018              Clinical Advisor, Potrero Medical

2019 - present              Scientific Advisory Board member (unpaid), Deep Blue Medical Advances, Inc.

2020              Co-Inventor, DERMASEAL – an advanced wound care product to treat diabetic foot ulcers.

2021 - present              Scientific Advisor and Member, DSMB (unpaid), AbSolutions Med, Inc.

PATENTS

2016              United States Patent No. 9,333,245 (issued May 10, 2016): Methods and Compositions for Treating Wounds and Reducing the Risk of Incisional Hernias.

2020              United States Patent Application No. 63/072,753 (filed August 31, 2020): Storage Stable Films Comprising Fibrin and/or Fibrinogen.

13 November 2024